An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

By Henriksen Katrine   Rasmussen Birgitte   Lykkesfeldt Anne   Møller Susanne   Ejlertsen Bent   Mouridsen Henning  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 522-531

Informa Healthcare

Access to resources Recommend Favorite

Should Patients with Advanced Colorectal Cancer be Treated with Chemotherapy?

By Blijham G.H.   Labianca R.   Bleiberg H.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 815-824

Elsevier

Access to resources Recommend Favorite

Survival of untreated advanced colorectal cancer patients

By  

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 731-733

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of predictive markers for patients with advanced colorectal cancer

By Byström Per   Berglund Åke   Nygren Peter   Wernroth Lisa   Johansson Birgitta   Larsson Anders   Glimelius Bengt  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 849-859

Informa Healthcare

Access to resources Recommend Favorite

Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer - report of a feasibility study

By Walker L.G.   Heys S.D.   Walker M.B.   Ogston K.   Miller I.D.   Hutcheon A.W.   Sarkar T.K.   Ah-See A.K.   Eremin O.  

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1783-1788

Elsevier

Access to resources Recommend Favorite